← Back to guidelines
Anesthesiology3 papers

Dengue with warning signs

Last edited:

Overview

Dengue, a viral infection transmitted primarily by Aedes mosquitoes, poses significant health risks globally, particularly in tropical and subtropical regions. While the majority of dengue cases occur in younger populations, recent evidence highlights a notable vulnerability among elderly individuals. This demographic faces heightened risks due to underlying chronic conditions and immunosenescence, which can lead to atypical presentations and more severe clinical outcomes. Understanding the specific challenges faced by elderly patients with dengue is crucial for effective clinical management and public health strategies. Further epidemiological studies are needed to fully elucidate the extent of dengue risks in elderly populations [PMID:20602028].

Epidemiology

The epidemiology of dengue in elderly populations remains underexplored compared to younger age groups, yet emerging evidence suggests a concerning trend. Elderly individuals, often characterized by a higher prevalence of comorbidities such as hypertension, diabetes, and cardiovascular diseases, are increasingly recognized as being at greater risk for dengue infection [PMID:20602028]. These comorbidities not only complicate the clinical presentation but also potentially exacerbate the severity of dengue disease. Public health initiatives should consider targeted surveillance and preventive measures for elderly populations to mitigate these risks. The limited data available underscore the necessity for comprehensive studies to better understand the epidemiology and risk factors specific to this demographic [PMID:20602028].

Clinical Presentation

Elderly patients with dengue often present with clinical features that can be atypical or masked by pre-existing chronic conditions, making early diagnosis challenging. Common symptoms such as fever, headache, and myalgia may be less prominent or overshadowed by symptoms related to underlying diseases like renal impairment or heart failure. Immunosenescence in the elderly can lead to a broader spectrum of clinical manifestations, including gastrointestinal symptoms, neurological complications, and hemorrhagic manifestations, which may not be typical in younger patients [PMID:20602028]. Clinicians must maintain a high index of suspicion for dengue in elderly patients presenting with unexplained fever or multi-system involvement, especially in endemic areas. A thorough history and physical examination, coupled with vigilance for warning signs, are essential for timely intervention [PMID:20602028].

Diagnosis

Diagnosing dengue in elderly patients requires a multifaceted approach due to the potential overlap with chronic conditions and atypical presentations. Laboratory confirmation through serological tests (e.g., NS1 antigen tests, IgM/IgG antibodies) and molecular diagnostics (RT-PCR) remains crucial. However, interpreting these results in the context of fluctuating chronic disease markers can be complex. Monitoring for warning signs such as persistent vomiting, severe abdominal pain, rapid breathing, or significant bleeding is particularly important in this population, as these indicators can signal severe dengue (dengue hemorrhagic fever or dengue shock syndrome) [PMID:20602028]. Given the atypical presentations, clinicians should consider dengue in their differential diagnosis even when initial symptoms seem unrelated to viral infection, ensuring comprehensive testing and clinical vigilance [PMID:20602028].

Management

The management of dengue in elderly patients necessitates a nuanced approach, taking into account their unique vulnerabilities. Supportive care remains the cornerstone of treatment, focusing on fluid management to prevent dehydration and shock, particularly in those with warning signs. Given the high prevalence of chronic diseases among the elderly, careful consideration of drug interactions and polypharmacy is essential. The cited evidence highlights the critical importance of avoiding exacerbating conditions, particularly the use of salicylates (e.g., aspirin), which can increase the risk of bleeding and worsen coagulation abnormalities associated with severe dengue [PMID:20602028]. Close monitoring of vital signs, renal function, and coagulation profiles is imperative. Additionally, managing pain and fever with safer alternatives like paracetamol is recommended to prevent complications [PMID:20602028].

Complications

Elderly dengue patients are at a heightened risk for severe complications, including dengue hemorrhagic fever and dengue shock syndrome, which can be life-threatening. Self-medication with over-the-counter drugs, particularly nonsteroidal anti-inflammatory drugs (NSAIDs) like salicylates, has been implicated in exacerbating these complications. Case studies illustrate that such practices can lead to increased bleeding tendencies and more severe clinical outcomes, underscoring the need for strict adherence to prescribed treatments and avoidance of self-medication [PMID:20602028]. Other complications may include organ dysfunction (e.g., liver, kidney), encephalopathy, and disseminated intravascular coagulation (DIC), all of which require prompt recognition and specialized management to mitigate morbidity and mortality risks [PMID:20602028].

Special Populations

The case of an 80-year-old woman with dengue complications vividly illustrates the heightened vulnerability of elderly populations. This demographic often experiences more severe clinical conditions, higher rates of hospitalization, and significantly increased mortality compared to younger patients [PMID:20602028]. The presence of multiple comorbidities in elderly individuals complicates both the clinical presentation and management, necessitating a multidisciplinary approach involving infectious disease specialists, geriatricians, and other relevant specialists. Tailored public health interventions and clinical guidelines that specifically address the needs of elderly dengue patients are urgently required to improve outcomes and reduce mortality rates [PMID:20602028].

Key Recommendations

  • Enhanced Surveillance: Implement targeted surveillance systems to monitor dengue incidence and severity in elderly populations to inform public health strategies.
  • Early Recognition: Clinicians should maintain a high index of suspicion for dengue in elderly patients presenting with unexplained fever or multi-system symptoms, especially in endemic regions.
  • Comprehensive Testing: Utilize a combination of serological tests and molecular diagnostics to confirm dengue diagnosis, considering the atypical presentations common in elderly patients.
  • Supportive Care: Prioritize supportive care measures, focusing on fluid management and close monitoring of vital signs, renal function, and coagulation profiles.
  • Avoid Salicylates: Strictly avoid the use of salicylates and NSAIDs in elderly dengue patients to prevent exacerbation of bleeding risks and other complications.
  • Multidisciplinary Approach: Employ a multidisciplinary team approach involving infectious disease specialists and geriatricians to manage complex cases effectively.
  • Patient Education: Educate elderly patients and caregivers about the risks of self-medication and the importance of adhering to prescribed treatments to prevent severe complications.
  • References

    1 Gorzoni ML, Massaia IF, Pires SL. Dengue in an elderly patient. Revista do Instituto de Medicina Tropical de Sao Paulo 2010. link

    1 papers cited of 3 indexed.

    Original source

    1. [1]
      Dengue in an elderly patient.Gorzoni ML, Massaia IF, Pires SL Revista do Instituto de Medicina Tropical de Sao Paulo (2010)

    HemoChat

    by SPINAI

    Evidence-based clinical decision support powered by SNOMED-CT, Neo4j GraphRAG, and NASS/AO/NICE guidelines.

    ⚕ For clinical reference only. Not a substitute for professional judgment.

    © 2026 HemoChat. All rights reserved.
    Research·Pricing·Privacy & Terms·Refund·SNOMED-CT · NASS · AO Spine · NICE · GraphRAG